Parametric Portfolio Associates’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $16.5M | Sell |
269,677
-4,903
| -2% | -$300K | 0.01% | 1074 |
|
|
2021
Q4 | $14.4M | Buy |
274,580
+59,385
| +28% | +$3.11M | 0.01% | 1153 |
|
|
2021
Q3 | $8.02M | Sell |
215,195
-20,676
| -9% | -$771K | ﹤0.01% | 1506 |
|
|
2021
Q2 | $9.63M | Buy |
235,871
+119,017
| +102% | +$4.86M | 0.01% | 1424 |
|
|
2021
Q1 | $3.97M | Buy |
116,854
+3,530
| +3% | +$120K | ﹤0.01% | 2330 |
|
|
2020
Q4 | $3.6M | Sell |
113,324
-40,707
| -26% | -$1.29M | ﹤0.01% | 2293 |
|
|
2020
Q3 | $3.95M | Buy |
154,031
+32,305
| +27% | +$829K | ﹤0.01% | 2059 |
|
|
2020
Q2 | $3.13M | Buy |
121,726
+19,556
| +19% | +$502K | ﹤0.01% | 2209 |
|
|
2020
Q1 | $1.57M | Buy |
102,170
+50,491
| +98% | +$776K | ﹤0.01% | 2531 |
|
|
2019
Q4 | $1.77M | Buy |
51,679
+9,667
| +23% | +$332K | ﹤0.01% | 2766 |
|
|
2019
Q3 | $314K | Sell |
42,012
-9,821
| -19% | -$73.4K | ﹤0.01% | 3509 |
|
|
2019
Q2 | $673K | Buy |
51,833
+7,223
| +16% | +$93.8K | ﹤0.01% | 3242 |
|
|
2019
Q1 | $543K | Buy |
44,610
+28,501
| +177% | +$347K | ﹤0.01% | 3293 |
|
|
2018
Q4 | $183K | Sell |
16,109
-4,934
| -23% | -$56.1K | ﹤0.01% | 3679 |
|
|
2018
Q3 | $457K | Buy |
21,043
+331
| +2% | +$7.19K | ﹤0.01% | 3447 |
|
|
2018
Q2 | $366K | Sell |
20,712
-33,077
| -61% | -$585K | ﹤0.01% | 3475 |
|
|
2018
Q1 | $1.13M | Buy |
53,789
+34,419
| +178% | +$724K | ﹤0.01% | 2952 |
|
|
2017
Q4 | $280K | Buy |
19,370
+4,416
| +30% | +$63.8K | ﹤0.01% | 3601 |
|
|
2017
Q3 | $236K | Buy |
+14,954
| New | +$236K | ﹤0.01% | 3784 |
|
|
2017
Q2 | – | Sell |
-92,971
| Closed | -$1.51M | – | 4039 |
|
|
2017
Q1 | $1.51M | Buy |
92,971
+75,027
| +418% | +$1.22M | ﹤0.01% | 2629 |
|
|
2016
Q4 | $271K | Sell |
17,944
-10,096
| -36% | -$152K | ﹤0.01% | 3474 |
|
|
2016
Q3 | $427K | Buy |
28,040
+3,407
| +14% | +$51.9K | ﹤0.01% | 3242 |
|
|
2016
Q2 | $956K | Buy |
24,633
+14,870
| +152% | +$577K | ﹤0.01% | 2860 |
|
|
2016
Q1 | $271K | Buy |
9,763
+5,220
| +115% | +$145K | ﹤0.01% | 3640 |
|
|
2015
Q4 | $244K | Buy |
+4,543
| New | +$244K | ﹤0.01% | 3643 |
|